TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Investing
4 Reasons Your Marijuana Investment Could End in Tears
Dividend Stocks
How the Path to Wealth Runs Through the $100,000 Mark
Investing
Canopy Growth Corp.’s Next Move Could Propel Aphria Inc.
Investing
Canopy Growth Corp. Has Entered a New Realm: Investors, Rejoice With Caution
Investing
Watching an Industry Move Forward
Investing
Canopy Growth Corp.: Here Comes the Crash?
Investing
Are Marijuana Companies Reporting Fictitious Earnings?
Investing
Cannabis Investors: Could the Opioid Crisis Derail the Recreational Marijuana Train?
Investing
What Canopy Growth Corp. Investors Can Take Away From Warren Buffett’s Annual Letter
Investing
Canopy Growth Corp.: The Pros and Cons of Owning This Stock
Investing
Is Aphria Inc. the Best Marijuana Stock?